BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23393363)

  • 1. Ablative or palliative stereotactic body radiotherapy with helical tomotherapy for primary or metastatic lung tumor.
    Marcenaro M; Vagge S; Belgioia L; Agnese D; Lamanna G; Mantero E; Gusinu M; Garelli S; Cavagnetto F; Agostinelli S; Corvò R
    Anticancer Res; 2013 Feb; 33(2):655-60. PubMed ID: 23393363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility report of image guided stereotactic body radiotherapy (IG-SBRT) with tomotherapy for early stage medically inoperable lung cancer using extreme hypofractionation.
    Hodge W; Tomé WA; Jaradat HA; Orton NP; Khuntia D; Traynor A; Weigel T; Mehta MP
    Acta Oncol; 2006; 45(7):890-6. PubMed ID: 16982555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: excellent local control.
    Videtic GM; Stephans K; Reddy C; Gajdos S; Kolar M; Clouser E; Djemil T
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):344-9. PubMed ID: 19765913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases.
    Rusthoven KE; Kavanagh BD; Burri SH; Chen C; Cardenes H; Chidel MA; Pugh TJ; Kane M; Gaspar LE; Schefter TE
    J Clin Oncol; 2009 Apr; 27(10):1579-84. PubMed ID: 19255320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local control of metastatic lung tumors treated with SBRT of 48 Gy in four fractions: in comparison with primary lung cancer.
    Hamamoto Y; Kataoka M; Yamashita M; Shinkai T; Kubo Y; Sugawara Y; Inoue T; Sakai S; Aono S; Takahashi T; Semba T; Uwatsu K
    Jpn J Clin Oncol; 2010 Feb; 40(2):125-9. PubMed ID: 19825814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose radiotherapy using helical tomotherapy for vertebral metastasis: early clinical outcomes and cord dose specification.
    Lee DS; Kwak YK; Jeong SM; Song JH; Kang YN; Lee SN; Jang HS; Kim YS; Yoon SC; Choi BO
    Jpn J Clin Oncol; 2013 Jun; 43(6):646-53. PubMed ID: 23613190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer.
    Lanni TB; Grills IS; Kestin LL; Robertson JM
    Am J Clin Oncol; 2011 Oct; 34(5):494-8. PubMed ID: 20805737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.
    Salazar OM; Sandhu TS; Lattin PB; Chang JH; Lee CK; Groshko GA; Lattin CJ
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):707-15. PubMed ID: 18455322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus.
    Song SY; Choi W; Shin SS; Lee SW; Ahn SD; Kim JH; Je HU; Park CI; Lee JS; Choi EK
    Lung Cancer; 2009 Oct; 66(1):89-93. PubMed ID: 19168260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Effects Between Central and Peripheral Stage I Lung Cancer Using Image-Guided Stereotactic Body Radiotherapy via Helical Tomotherapy.
    He J; Huang Y; Shi S; Hu Y; Zeng Z
    Technol Cancer Res Treat; 2015 Dec; 14(6):701-7. PubMed ID: 25911646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Size matters: a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT).
    Dunlap NE; Larner JM; Read PW; Kozower BD; Lau CL; Sheng K; Jones DR
    J Thorac Cardiovasc Surg; 2010 Sep; 140(3):583-9. PubMed ID: 20478576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic body radiotherapy with helical tomotherapy for pain palliation in spine metastasis.
    Kim MS; Keum KC; Cha JH; Kim JH; Seong JS; Lee CG; Nam KC; Koom WS
    Technol Cancer Res Treat; 2013 Aug; 12(4):363-70. PubMed ID: 23448578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer.
    Grills IS; Mangona VS; Welsh R; Chmielewski G; McInerney E; Martin S; Wloch J; Ye H; Kestin LL
    J Clin Oncol; 2010 Feb; 28(6):928-35. PubMed ID: 20065181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Outcome of three-dimensional conformal radiotherapy for early stage non-small cell lung cancer patients who met or not inclusion criteria for stereotactic-body radiation therapy].
    Kołodziejczyk M; Kępka L; Tyc-Szczepaniak D; Wierzchowski M
    Pneumonol Alergol Pol; 2011; 79(5):326-36. PubMed ID: 21861256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy.
    Baumann P; Nyman J; Hoyer M; Wennberg B; Gagliardi G; Lax I; Drugge N; Ekberg L; Friesland S; Johansson KA; Lund JA; Morhed E; Nilsson K; Levin N; Paludan M; Sederholm C; Traberg A; Wittgren L; Lewensohn R
    J Clin Oncol; 2009 Jul; 27(20):3290-6. PubMed ID: 19414667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CyberKnife radiosurgery for stage I lung cancer: results at 36 months.
    Brown WT; Wu X; Fayad F; Fowler JF; Amendola BE; García S; Han H; de la Zerda A; Bossart E; Huang Z; Schwade JG
    Clin Lung Cancer; 2007 Sep; 8(8):488-92. PubMed ID: 17922973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term local control achieved after hypofractionated stereotactic body radiotherapy for adrenal gland metastases: a retrospective analysis of 34 patients.
    Scorsetti M; Alongi F; Filippi AR; Pentimalli S; Navarria P; Clerici E; Castiglioni S; Tozzi A; Reggiori G; Mancosu P; Ricardi U
    Acta Oncol; 2012 May; 51(5):618-23. PubMed ID: 22263925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing outcomes of stereotactic body radiotherapy with intensity-modulated radiotherapy for patients with locally advanced unresectable pancreatic cancer.
    Lin JC; Jen YM; Li MH; Chao HL; Tsai JT
    Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):259-64. PubMed ID: 25629569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the pattern of failure is distant.
    Bradley JD; El Naqa I; Drzymala RE; Trovo M; Jones G; Denning MD
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1146-50. PubMed ID: 19800181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-individualized stereotactic body radiotherapy for T1-3N0 non-small cell lung cancer: long-term results and efficacy of adjuvant chemotherapy.
    Chen Y; Guo W; Lu Y; Zou B
    Radiother Oncol; 2008 Sep; 88(3):351-8. PubMed ID: 18722684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.